Table 1.

Demographics of patients with monoclonal gammopathy and paraproteins.

ID	Age	Gender	LC	sCr	U[P/C]	Hematological classification	Renal histology	Disease duration
1	78	m	λ	1.03	49	MM	n.a.	10
2	71	f	κ	1.07	194	MGUS	n.a.	5
3	82	f	κ	0.90	256	MM	n.a.	3
4	81	f	λ	0.97	659	AL amyloidosis	n.a.	3
5	88	f	κ	1.15	1	MGRS	n.a.	6
6	50	m	κ	1.34	214	MM	n.a.	1
7	69	m	κ	0.99	115	MGUS	n.a.	7
8	81	f	λ	0.72	58	MM	n.a.	10
9	70	f	λ	1.11	112	MGRS	LCPT	1
10	77	f	λ	0.64	81	MM	n.a.	10
11	60	m	λ	1.07	115	MM	n.a.	2
12	79	m	λ	2.69	460	MGRS	FGN	2
13	64	f	κ	0.90	274	MM	n.a.	6
14	75	m	λ	0.79	245	MM	n.a.	6
15	84	m	κ	1.94	283	MM	n.a.	9
16	69	m	λ	0.66	1	MGUS	n.a.	6
17	81	m	κ	0.86	118	MM	n.a.	1
18	79	m	λ	1.05	228	MM	n.a.	1
19	77	m	λ	2.43	1714	MM	PGNMID	4
20	78	m	κ	2.90	1091	MGRS	no pathology	6
21	85	f	λ	0.91	254	MM	n.a.	28
22	73	m	κ	0.97	54	MM	n.a.	2

LC, light chain; λ, lambda light chain; κ, kappa light chain; FGN, monotypic fibrillary glomerulonephritis; LCPT, light-chain proximal tubulopathy; MGRS, monoclonal gammopathy with renal significance; MGUS, monoclonal gammopathy with undefined significance; MM, multiple myeloma; n.a., not available; PGNMID, proliferative glomerulonephritis and monoclonal immunoglobulin deposits; U[P/C], urinary protein/creatinine ratio given in mg/g; sCr, serum creatinine given in mg/dL after 1-year follow-up. Disease duration is given in years.